Concepedia

Jakob T. Rostøl

JT

Statistics

Publications

11

Citations

1.3K

H-Index

11

Active since

2017

Affiliations

Rockefeller University(Current)

Howard Hughes Medical Institute

Imperial College London

Tri-Institutional PhD Program in Chemical Biology

ETH Zurich

Jakob T. Rostøl is an author at Rockefeller University specializing in life sciences, crispr-cas systems, and molecular biology.

ORCID

Publications per year

2017–2024

11

Publications

11

Type III CRISPR–Cas systems produce cyclic oligoadenylate second messengers

Ole Niewoehner, Carmela Garcia‐Doval, Jakob T. Rostøl et al. · Nature · 2017 · 505 citations

, , +10

Non-specific degradation of transcripts promotes plasmid clearance during type III-A CRISPR–Cas immunity

Jakob T. Rostøl, Luciano A. Marraffini · Nature Microbiology · 2019 · 167 citations · Full text

, , +10

Bacteriophages benefit from mobilizing pathogenicity islands encoding immune systems against competitors

Alfred Fillol-Salom, Jakob T. Rostøl, Adaeze Doris Ojiogu et al. · Cell · 2022 · 129 citations · Full text

, , +14

The Card1 nuclease provides defence during type III CRISPR immunity

Jakob T. Rostøl, Wei Xie, Vitaly Kuryavyi et al. · Nature · 2021 · 127 citations · Full text

, , +6

Activation and self-inactivation mechanisms of the cyclic oligoadenylate-dependent CRISPR ribonuclease Csm6

Carmela Garcia‐Doval, Frank Schwede, Christian Berk et al. · Nature Communications · 2020 · 102 citations · Full text

, , +15

1–5 of 11